Definium Therapeutics Statistics
Total Valuation
DFTX has a market cap or net worth of $4.38 billion. The enterprise value is $3.37 billion.
| Market Cap | 4.38B |
| Enterprise Value | 3.37B |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DFTX has 136.90 million shares outstanding. The number of shares has increased by 34.19% in one year.
| Current Share Class | 136.90M |
| Shares Outstanding | 136.90M |
| Shares Change (YoY) | +34.19% |
| Shares Change (QoQ) | +24.09% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 85.04% |
| Float | 128.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 284.61 |
| PB Ratio | 4.67 |
| P/TBV Ratio | 4.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.53, with a Debt / Equity ratio of 0.04.
| Current Ratio | 15.53 |
| Quick Ratio | 15.46 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -51.91 |
Financial Efficiency
Return on equity (ROE) is -61.44% and return on invested capital (ROIC) is -27.01%.
| Return on Equity (ROE) | -61.44% |
| Return on Assets (ROA) | -24.23% |
| Return on Invested Capital (ROIC) | -27.01% |
| Return on Capital Employed (ROCE) | -25.25% |
| Weighted Average Cost of Capital (WACC) | 16.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.18M |
| Employee Count | 106 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +163.84% in the last 52 weeks. The beta is 2.21, so DFTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.21 |
| 52-Week Price Change | +163.84% |
| 50-Day Moving Average | 36.07 |
| 200-Day Moving Average | 30.43 |
| Relative Strength Index (RSI) | 41.43 |
| Average Volume (20 Days) | 1,606,564 |
Short Selling Information
The latest short interest is 9.61 million, so 7.02% of the outstanding shares have been sold short.
| Short Interest | 9.61M |
| Short Previous Month | 10.04M |
| Short % of Shares Out | 7.02% |
| Short % of Float | 7.51% |
| Short Ratio (days to cover) | 5.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -254.15M |
| Pretax Income | -337.48M |
| Net Income | -337.48M |
| EBITDA | n/a |
| EBIT | -254.15M |
| Earnings Per Share (EPS) | -$2.96 |
Balance Sheet
The company has $1.05 billion in cash and $36.66 million in debt, with a net cash position of $1.01 billion or $7.38 per share.
| Cash & Cash Equivalents | 1.05B |
| Total Debt | 36.66M |
| Net Cash | 1.01B |
| Net Cash Per Share | $7.38 |
| Equity (Book Value) | 968.03M |
| Book Value Per Share | 7.07 |
| Working Capital | 984.03M |
Cash Flow
| Operating Cash Flow | -191.36M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -191.36M |
| FCF Per Share | -$1.40 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DFTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -34.19% |
| Shareholder Yield | -34.19% |
| Earnings Yield | -9.23% |
| FCF Yield | -4.24% |
Analyst Forecast
The average price target for DFTX is $72.78, which is 127.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.78 |
| Price Target Difference | 127.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |